These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15971544)

  • 1. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current practice in the operation and validation of aseptic blow-fill-seal processes.
    Ljungqvist B; Reinmüller B; Löfgren A; Dewhurst E
    PDA J Pharm Sci Technol; 2006; 60(4):254-8. PubMed ID: 17089694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management, cGMP, and the evolution of aseptic processing technology.
    Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A
    PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 5. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing and controlling microbial contamination in cell cultures.
    Coté R
    Curr Protoc Cell Biol; 2001 May; Chapter 1():Unit 1.5. PubMed ID: 18228293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current regulatory issues regarding parenteral inspections.
    Avallone H
    J Parenter Sci Technol; 1989; 43(1):3-7. PubMed ID: 2926605
    [No Abstract]   [Full Text] [Related]  

  • 10. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological Control for Affinity Capture Chromatography Processing: An Industry Perspective.
    Murphy M; Bell BL; Moshi J; Grassi R; Forng RY; Salaman A; Jordi PW; Zaidi S; Goodnight M; Paul M; Keller A; Carpenter B; Hearty U; Willison-Parry D
    PDA J Pharm Sci Technol; 2018; 72(2):213-221. PubMed ID: 29444992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control aspects of aseptically produced products.
    Avallone HL
    J Parenter Sci Technol; 1985; 39(2):75-9. PubMed ID: 3989616
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenging our aseptic skills using more-rigorous media-fill tests.
    Kastango ES
    Am J Health Syst Pharm; 2012 Jul; 69(14):1197. PubMed ID: 22761072
    [No Abstract]   [Full Text] [Related]  

  • 15. Sterilization and filtration.
    Coté RJ
    Curr Protoc Cell Biol; 2001 May; Chapter 1():Unit 1.4. PubMed ID: 18228292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiological in-process control in drug manufacture].
    Seyfarth VH
    Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR; Robinson JE
    J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing toxicology in RiskMAPP: setting ADEs based on the subsequent drug substance.
    Bercu JP; Sharnez R; Dolan DG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):157-61. PubMed ID: 22921793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aseptic processing of non-preserved parenterals.
    Avallone HL
    J Parenter Sci Technol; 1989; 43(3):113. PubMed ID: 2732849
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
    Katayama H; Toda A; Tokunaga Y; Katoh S
    PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.